Risk factors for hemorrhagic cystitis in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation
Open Access
- 3 April 2025
- journal article
- pediatrics
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1558099
Abstract
Purpose: To investigate the risk factors for hemorrhagic cystitis (HC) in children with severe beta-thalassemia after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Methods: The clinical data of 152 children under the age of 15 who underwent allo-HSCT between January 2011 and December 2021 were retrospectively analyzed. The incidence of HC and related variables were evaluated using univariate analysis. Variables with statistical significance (P < 0.05) were included in a multivariable logistic regression model to identify independent risk factors for HC.Results: Among the 152 children, 42 developed HC, with an incidence rate of 27.63%. The median onset time of HC was 25 days (IQR: 10–38.75 days). Univariate analysis indicated that older transplantation age, elevated pre-transplant serum ferritin levels, cytomegalovirus (CMV) infection, and prolonged neutrophil engraftment time were associated with HC occurrence (P < 0.05). Multivariable logistic regression further confirmed that older transplantation age (OR 1.236, 95% CI: 1.031–1.531, P = 0.033), elevated pre-transplant ferritin levels (OR 1.053, 95% CI: 1.028–1.086, P < 0.01), CMV infection (OR 11.522, 95% CI: 2.912–76.345, P = 0.002), and prolonged neutrophil engraftment time (OR 1.385, 95% CI: 1.109–1.793, P < 0.01) were independent risk factors for HC.Conclusion: Older transplantation age (>5.95 age years old), elevated pre-transplant serum ferritin levels, CMV infection, and delayed neutrophil engraftment are independent risk factors for HC in children with severe beta-thalassemia after allo-HSCT. Early identification and intervention for these risk factors are crucial in reducing the incidence of HC.Keywords
This publication has 25 references indexed in Scilit:
- Endocrinopathies in beta thalassemia: a narrative reviewHormones, 2023
- Haploidentical Cord Blood Transplantation with 8 mg/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg/kg Antithymocyte Globulin in the Treatment of Acute LeukemiaTransplantation and Cellular Therapy, 2023
- The Clinical Phenotypes of Alpha ThalassemiaHematology/Oncology Clinics of North America, 2023
- Hematopoietic Stem Cell Transplantation in ThalassemiaHematology/Oncology Clinics of North America, 2023
- CMV infection is a risk factor for hemorrhagic cystitis after hematopoietic stem cell transplantationAnnals of Hematology, 2023
- Current status of beta‐thalassemia and its treatment strategiesMolecular Genetics & Genomic Medicine, 2021
- The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overloadKidney International, 2021
- Hemorrhagic cystitis after hematopoietic stem cell transplantation: A challenge for the pediatric urologistJournal of Pediatric Urology, 2018
- Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamideInternational Immunopharmacology, 2018
- Pediatric hemorrhagic cystitisJournal of Pediatric Urology, 2009